Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nerve Growth Factor Eye Drops as a Novel Treatment for Vision Loss in Patients With Retinitis Pigmentosa: From Preclinical to Clinical Phase II Trial

NCT02609165 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.

NCT NCT02609165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02609165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nerve Growth Factor Eye Drops as a Novel Treatment for Vision Loss in Patients With Retinitis Pigmentosa: From Preclinical to Clinical Phase II Trial
Lead sponsor
Ospedale San Raffaele
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2015
Completion date
February 28, 2017
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystoid macular edema, retinitis pigmentosa